Finance

Lists
PPLPHARMA:NSE
Piramal Pharma Ltd (Mumbai)
₹238.30
+0.23%
(+0.54) 1D
ኖቬም 5, 3:30:02 ከሰዓት ጂ ኤም ቲ+530  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
₹240.80
High
₹241.27
Low
₹236.45
Mkt. cap
315.37 ቢ
Avg. vol.
8.40 ሚ
Volume
3.91 ሚ
52-wk high
₹243.20
52-wk low
₹132.30
EPS
-₹1.58
No. of employees
7 ሺ
Open
₹240.80
High
₹241.27
Low
₹236.45
Mkt. cap
315.37 ቢ
Avg. vol.
8.40 ሚ
Volume
3.91 ሚ
52-wk high
₹243.20
52-wk low
₹132.30
EPS
-₹1.58
No. of employees
7 ሺ
News stories
From web sources and news partners
ABC News - Breaking News, Latest News and Videos
ABC News - Breaking News, Latest News and Videos
·
ከ50 ደቂቃዎች በፊት
Dow plunges 1,200 points, shedding most of midterm results stock rally
Axios
Axios
·
ከ47 ደቂቃዎች በፊት
Nasdaq plummets toward correction territory
The Block
The Block
·
ከ18 ደቂቃዎች በፊት
Canary's Injective ETF debuts on Nasdaq with exposure to staking rewards
CNN
CNN
·
ከ1 ሰዓት በፊት
Nasdaq plunges into correction territory as midterm results raise fresh questions about AI boom
About Piramal Pharma Ltd (Mumbai)
CEOPeter DeYoung
Employees7.12 ሺ
Founded2020
Headquarters-
SectorPharmaceutical industry
Industry-
Websitepiramalpharma.com
Last report
28 ኦክቶ 2026
Fiscal period
Q2 2027
₹0.04 / -₹0.38
+110.57%beat
Revenue / Est. (INR)
26.17 ቢ / 23.58 ቢ
+11.00%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
21.40 ቢ
27.52 ቢ
22.70 ቢ
26.17 ቢ
Cost of goods sold
7.86 ቢ
13.95 ቢ
8.52 ቢ
9.06 ቢ
Cost of revenue
7.86 ቢ
13.95 ቢ
8.52 ቢ
9.06 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.00 ቢ
8.19 ቢ
6.76 ቢ
7.14 ቢ
Operating expense
13.71 ቢ
11.09 ቢ
14.46 ቢ
15.95 ቢ
Total operating expenses
21.57 ቢ
25.04 ቢ
22.98 ቢ
25.01 ቢ
Operating income
-170.10 ሚ
2.47 ቢ
-283.50 ሚ
1.16 ቢ
Other non operating income
432.40 ሚ
-977.90 ሚ
894.10 ሚ
359.30 ሚ
EBT including unusual items
-938.60 ሚ
430.00 ሚ
-74.60 ሚ
816.30 ሚ
EBT excluding unusual items
-527.50 ሚ
1.40 ቢ
-74.60 ሚ
816.30 ሚ
Income tax expense
423.30 ሚ
518.30 ሚ
619.30 ሚ
766.00 ሚ
Effective tax rate
-45.10%
120.53%
-830.16%
93.84%
Other operating expenses
5.58 ቢ
723.30 ሚ
5.47 ቢ
6.48 ቢ
Net income
-1.36 ቢ
-88.30 ሚ
-693.90 ሚ
55.80 ሚ
Net profit margin
-6.36%
-0.32%
-3.06%
0.21%
Earnings per share
-0.72
1.32
-0.52
0.04
Interest and investment income
-
70.70 ሚ
-
-
Interest expense
-892.40 ሚ
-805.40 ሚ
-880.80 ሚ
-876.30 ሚ
Net interest expenses
-892.40 ሚ
-734.70 ሚ
-880.80 ሚ
-876.30 ሚ
Depreciation and amortization charges
2.13 ቢ
2.18 ቢ
2.24 ቢ
2.33 ቢ
EBITDA
1.68 ቢ
4.32 ቢ
1.57 ቢ
3.29 ቢ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች